剖宫产术后高剂量地塞米松:有希望信号还是边际获益?
本文评述Br J Anaesth同期一项随机临床试验,该试验比较择期剖宫产术后高剂量与低剂量静脉地塞米松的效果,仅观察到高剂量较低剂量的边际获益。作者指出高剂量地塞米松的额外镇痛获益证据仍不充分,产科人群数据缺乏,需针对严重急性术后疼痛和持续性疼痛高危患者开展个体化研究。
要点
- 低剂量静脉地塞米松可减少术后疼痛、阿片消耗及恶心呕吐。
- 剖宫产术后高剂量较低剂量地塞米松仅见边际获益。
- 需针对严重急性疼痛和持续性疼痛高危患者进一步研究。
核心结论
- 择期剖宫产术后高剂量较低剂量静脉地塞米松仅见边际获益。
- 高剂量地塞米松的额外镇痛获益证据仍不充分,产科人群数据缺乏。
研究设计与样本
- 本文为Br J Anaesth同期发表的随机临床试验的评述文章。
主要发现
- 该随机临床试验在择期剖宫产术后观察到高剂量较低剂量静脉地塞米松仅有边际获益。
临床怎么用
- 剖宫产术后地塞米松的剂量选择需权衡边际获益与证据不确定性。
- 可关注严重急性术后疼痛和持续性疼痛高危患者,探索个体化用药。
局限性
- 高剂量地塞米松额外镇痛获益的证据不充分。
- 产科患者中缺乏相关数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Low-dose intravenous dexamethasone reduces postoperative pain, opioid consumption, and postoperative nausea and vomiting compared with placebo after general and spinal anaesthesia. However, evidence of additional analgesic benefit from high-dose dexamethasone remains unconvincing, and data are lacking in obstetric patients. In this issue of the British Journal of Anaesthesia, a randomised clinical trial observed only modest benefits of high-dose compared with low-dose intravenous dexamethasone after elective Caesarean delivery. Further studies targeting personalised care in patients at particular risk of severe acute postoperative pain and persistent pain are required.
引用
- Lee CW, Leslie K. High-dose dexamethasone after Caesarean delivery: promising signal or marginal gain? Br J Anaesth. 2026. PMID: 42034557. doi:10.1016/j.bja.2026.03.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。